Synopsys, Inc. today announced Intel Custom Foundry's certification of digital and custom implementation tools from the Synopsys Galaxy™ Design Platform for Intel's 14-nanometer (nm) tri-gate process technology. The certification enables customers of Intel Custom Foundry to realize predictability in design closure while taking advantage of the power and performance benefits of the 14-nm tri-gate process.
TowerJazz, the global specialty foundry leader, and TowerJazz Panasonic Semiconductor Co., Ltd. (TPSCo) – a newly established company by Panasonic Corporation of which Tower Semiconductor Ltd. acquired 51%, and Synopsys, Inc., a global leader in electronic design automation (EDA) and semiconductor IP, today announced that they have qualified a 65 nanometer (nm) CMOS image sensor (CIS) interoperable process design kit (iPDK) to allow customers to design and develop new products using Synopsys’ custom design solution.
The nanoLED SEM image (pictured) by Eindhoven University of Technology (TU/e) recently won a competition held by Oxford Instruments Plasma Technology, and chosen from a large number of entries, all demonstrating unique and intriguing process results obtained using Oxford Instruments equipment.
Today, Micron Technology, Inc. announced a new addition to its expansive portfolio of flash storage products, providing a purpose-built solution for cost-sensitive consumer applications seeking high performance and reliability.
Broadcom Corporation, a global innovation leader in semiconductor solutions for wired and wireless communications, today announced the industry's lowest-power Gigabit Ethernet (GbE) switch for home gateways, small business switch systems and wireless router applications.
Nantero, the world leader in carbon nanotube electronics, today announced it has closed a $31.5 million Series E financing round, which included new investors and participation from existing investors Charles River Ventures, Draper Fisher Jurvetson, Globespan Capital Partners, and Harris & Harris Group.
Synopsys, Inc. today announced STMicroelectronics, a global semiconductor leader serving customers across the spectrum of electronics applications, has taped out their latest fully depleted silicon on insulator (FD-SOI) system on chip (SoC) using Synopsys' IC Compiler™ II place and route solution.
FUJIFILM Corporation (President: Shigehiro Nakajima) (hereafter, “Fujifilm”) and nano-electronics research institute, imec (CEO: Luc Van den hove), have demonstrated full-color organic light-emitting diodes (OLED) by using their jointly-developed photoresist technology for organic semiconductors, a technology that enables submicron patterning. This breakthrough result paves the way to producing high-resolution and large organic Electroluminescent(EL) displays and establishing cost-competitive manufacturing methods.
ANSYS, Inc. and TowerJazz, a leader in specialty foundry technology, are working to meet the growing demands for automotive, medical and Internet of Things (IoT) applications where product reliability and robustness are paramount. This collaboration has enabled TowerJazz to certify ANSYS® Totem™ and ANSYS® PathFinder™ software for its 180-nanometer (nm) process family design kits (PDKs) and reference design flow.
Xilinx, Inc. announced that it has collaborated with TSMC on the 7nm process and 3D IC technology for its next generation of All Programmable FPGAs, MPSoCs, and 3D ICs. The technology represents the fourth consecutive generation where the two companies have worked together on advanced process and CoWoS 3D stacking technology, and will become TSMC's fourth generation of FinFET technology. The collaboration will provide Xilinx a multi-node scaling advantage and build on its outstanding product, execution, and market success at 28nm, 20nm, and 16nm nodes.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.